IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells

Journal of Endocrinology

Volumn 179, Issue 2, 2003, Pages 267-274

  Jamali, R ^a   Bao, M ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; APOPTOSIS INHIBITOR; CASPASE 3; CELL MARKER; DNA FRAGMENT; INSULIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; AORTA MEDIA; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL STRUCTURE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DNA HISTONE INTERACTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; AORTA; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, IGF TYPE 1;

EID: 0344466714     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1790267     Document Type: Article

References (44)

1. Aoki M, Morishita R, Matsushita H, Nakano N, Hayashi SI, Tomita N, Yamamoto K, Moriguchi A, Higaki J & Ogihara T 1997 Serum deprivation-induced apoptosis accompanied by up-regulation of P53 and bax in human aortic vascular smooth muscle cells. Heart and Vessels. Supplement 12 71-75.
2. Arnqvist HJ 1974 Action of insulin on vascular and intestinal smooth muscle. Effects on amino acid transport, protein synthesis and accumulation of glucose carbon. Acta Physiologica Scandinavica 90 132-142.
3. Arnqvist HJ, Bornfeldt KE, Chen Y & Lindström T 1995 The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 44 58-66.
4. Avaughan ATM, Betti W & Villalobos MJ 2002 Surviving apoptosis. Apoptosis 7 173-177.
5. Bai HZ, Pollman MJ, Inishi Y & Gibbons GH 1999 Regulation of vascular smooth muscle cell apoptosis. Modulation of Bad by a phosphatidylinositol 3-kinase-dependent pathway. Circulation Research 85 229-237.
6. Banskota NK, Taub R, Zellner K, Olsen P & King GL 1989 Characterization of induction of proto-oncogene c-myc and cellular growth in human smooth muscle cells by insulin and IGF-I. Diabetes 38 123-129.
7. Bennett MR 1997 Apoptosis in vascular disease. Transplant Immunology 5 184-188.
8. Bennett MR & Boyle JJ 1998 Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138 3-9.
9. Bennett MR, Evan GI & Schwartz SM 1995 Apoptosis in human vascular smooth muscle cells derived from vessels and coronary atherosclerotic plaques. Journal of Clinical Investigation 95 2266-2274.
10. Bornfeldt KE, Gidlöf RA, Wasteson Å, Lake M, Skottner A & Arnqvist HJ 1991 Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34 307-313.
11. Chinnaiyan AM & Dixit V 1996 The cell-death machine. Current Biology 6 555-562.
12. Cohen JJ 1994 Apoptosis: physiologic cell death. Journal of Laboratory and Clinical Medicine 124 761-765.
13. Davies MJ 1996 Stability and instability: two faces of coronary atherosclerosis. Circulation 94 2013-2020.
14. Davies MJ, Richardson PD, Woolf N, Katz DR & Mann J 1993 Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. British Heart Journal 69 377-381.
15. Donnelly R, Emslie-Smith AM, Gardner ID & Morris AD 2000 Vascular complications of diabetes. British Medical Journal 320 1062-1066.
16. Ekman B, Nyström F & Arnqvist HJ 2000 Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. European Journal of Endocrinology 143 305-310.
17. Frystyk J, Skjærbæk C, Dinesen B & Ørskov H 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters 348 185-191.
18. Gabbiani G, Schmid E, Winter S, Chaponnier C, De Chastony C, Vandekerckhove J, Weber K & Franke WW 1981 Vascular smooth muscle cells differ from other smooth muscle cells: predominant of vimentin filaments and a specific α-type actin. PNAS 78 298-302.
19. Goetze S, Blaschke F, Stawowy P, Bruemmer D, Spencer C, Graf K, Gräfe M, Law RE & Flek E 2001 TNFα inhibits insulin antiapoptotic signalling in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 287 662-670.
20. Gouni-Berthold I, Berthold HK, Weber AA, Ko Y, Seul C, Vetter H & Sachinidis A 2001 Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway. Naunyn Schmiedebergís Archives of Pharmacology 363 215-221.
21. Hall JL, Matter CM, Wang X & Gibbons GH 2000 Hyperglycemia inhibits vascular smooth muscle cells apoptosis: mediator role of protein kinase C. Circulation Research 87 574-580.
22. Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Chalé JJ, Rosenfeld R & Tauber JP 1996 Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor(IGF)-I, and IGF-binding protein-3 in IDDM. Diabetologia 39 1498-1504.
23. Janicke RU, Sprengart ML, Wati MR & Porter AG 1998 Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. Journal of Biological Chemistry 273 9357-9360.
24. Jialal I, Crettaz M, Hachiya HL, Kahn CR, Moses AC, Buzney SM & King GL 1985 Characterization of the receptors for insulin and insulin-like growth factors on micro-and macrovascular tissues. Endocrinology 117 1222-1229.
25. Jung F, Haendeler J, Goebel C, Zeiher AM & Dimmeler S 2000 Growth factor-induced phosphoinoside 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovascular Research 48 148-157.
26. Kidd VJ 1998 Proteolytic activities that mediate apoptosis. Annual Review of Physiology 60 533-573.
27. King GL, Goodman AD, Buzney S, Moses A & Kahn CR 1985 Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. Journal of Clinical Investigation 75 1028-1036.
28. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C & Trüb T 2000 Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49 999-1005.
29. Lee PDK, Hintz RL, Rosenfeld RG & Benitz WE 1988 Presence of insulin like growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells. In Vitro Cellular and Developmental Biology 24 921-926.
30. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 265-275.
31. McCarthy NJ & Bennett MR 2000 The regulation of vascular smooth muscle cell apoptosis. Cardiovascular Research 45 747-755.
32. Nilsson J, Ksiazek T, Heldin C & Thyberg J 1983 Effects of colchicines on DNA synthesis, endocytosis and fine structure of cultured arterial smooth muscle cells. Experimental Cell Research 143 367-375.
33. Okura Y, Brink M, Zahid AA, Anwar A & Delafontanine P 2001 Decreased expression of insulin-like growth factor-I and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. Journal of Molecular and Cellular Cardiology 33 1777-1789.
34. Olsson PO, Arnqvist HJ & von Schenck H 1988 Free insulin profiles during subcutaneous insulin regimens in diabetes mellitus type 1. Diabete et Metabolisme 14 253-258.
35. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B & Baserga R 1999 Multiple signalling pathways of the insulin-like growth factor-I receptor in protection from apoptosis. Molecular and Cellular Biology 19 7203-7215.
36. Podesta F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C & Lorenzi M 2000 Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. American Journal of Pathology 156 1025-1032.
37. Pollman MJ, Yamada T, Horiuchi M & Gibbons GH 1996 Vasoactive substances regulate vascular smooth muscle cell apoptosis. Circulation Research 79 748-756.
38. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S & Baserga R 1994 Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Research 54 4848-4850.
39. Ross R 1971 The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. Journal of Cell Biology 50 172-186.
40. Ruiz-Torres A, Melon J & Munoz FJ 1998 Insulin stimulates collagen synthesis in VSMC from elderly patients. Gerontology 44 144-148.
41. Saini KS & Walker NI 1998 Biochemical and molecular mechanisms regulating apoptosis. Molecular and Cellular Biochemistry 178 9-25.
42. Shichiri M, Yokokura M, Marumo, F & Hirata Y 2000 Endothelin-1 inhibits apoptosis of vascular smooth cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 20 989-997.
43. Skalli O, Rapraz P, Trzeciak A, Benzonana G, Gillessen D & Gabbiani G 1986 A monoclonal antibody against α-smooth actin: a new probe for smooth muscle differentiation. Journal of Cell Biology 103 2787-2796.
44. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillaancourt JP et al. 1997 A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. Journal of Biological Chemistry 272 17907-17911.